A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia

2015 ◽  
Vol 110 (3) ◽  
pp. 423-431 ◽  
Author(s):  
Kenichi Hosonuma ◽  
Ken Sato ◽  
Yuichi Yamazaki ◽  
Masatoshi Yanagisawa ◽  
Hiroaki Hashizume ◽  
...  
2017 ◽  
Vol 1 ◽  
pp. s78
Author(s):  
Steven Dayan ◽  
Corey S Maas ◽  
Pearl E Grimes ◽  
Kenneth Beer ◽  
Gary Monheit ◽  
...  

Abstract Not AvailableDisclosures: Study supported by Allergan.


Hepatology ◽  
2008 ◽  
Vol 49 (1) ◽  
pp. 337-338 ◽  
Author(s):  
Lucy J. Walker ◽  
Julia Newton ◽  
David E. J. Jones ◽  
Margaret F. Bassendine

2020 ◽  
Vol 46 (11) ◽  
pp. 2015-2025 ◽  
Author(s):  
Sung Yeon Hwang ◽  
◽  
Seung Mok Ryoo ◽  
Jong Eun Park ◽  
You Hwan Jo ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-9 ◽  
Author(s):  
Yan Zhang ◽  
Jie Lu ◽  
Weiqi Dai ◽  
Fan Wang ◽  
Miao Shen ◽  
...  

A meta-analysis was performed of RCTs comparing therapies that combine UDCA and corticosteroids with UDCA monotherapy. In this paper, we found that the combination therapy of UDCA and corticosteroids was more effective for PBC-AIH.


Sign in / Sign up

Export Citation Format

Share Document